Operator of a human embryonic stem cell company. The company develops drugs using the properties of stem cells and their derivatives as part of the drug discovery process.
Isolated cytotrophoblast stem cell expresses hla-g and hla class i antigen; cytokeratin 7; stage specific embryonic antigen 1; human placental lactogen; caudal related homeobox; vimentin; cd9 marker; chimeric cell for the modulation of cell/tissue rejection in transplantation therapy